Neurogene (NGNE) Receivables - Net (2013 - 2015)
Neurogene posted quarterly Receivables - Net of $32000.0 for Q4 2015, down 50.77% year-on-year from $65000.0 in Q4 2014, and up 68.42% on a QoQ basis from $19000.0 in Q3 2015.
Neurogene (NGNE) has 3 years of Receivables - Net data on file, last reported at $32000.0 in Q4 2015.
- For the quarter ending Q4 2015, Receivables - Net fell 50.77% year-over-year to $32000.0; the trailing twelve-month figure through Dec 2015 stood at $32000.0 (down 50.77% YoY), and the FY2015 full-year result was $32000.0, down 50.77% from the prior year.
- Receivables - Net for Q4 2015 stood at $32000.0, up from $19000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $76243.0 in Q3 2014 and bottomed at $19000.0 in Q3 2015.
- The 3-year median for Receivables - Net is $57000.0 (2015), against an average of $49898.9.
- The widest annual swing landed in 2014, when Receivables - Net surged 132.59%; it then slumped 75.08% in 2015.
- A 3-year view of Receivables - Net shows it stood at $27946.0 in 2013, then jumped by 132.59% to $65000.0 in 2014, then plunged by 50.77% to $32000.0 in 2015.
- The last three Receivables - Net figures came in at $32000.0 (Q4 2015), $19000.0 (Q3 2015), and $72000.0 (Q2 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Neurogene | 632.14 Mn | 632.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 32,000.00 |
| Dec 31, 2015 | 32,000.00 |
| Sep 30, 2015 | 19,000.00 |
| Sep 30, 2015 | 19,000.00 |
| Jun 30, 2015 | 72,000.00 |
| Jun 30, 2015 | 72,000.00 |
| Mar 31, 2015 | 57,000.00 |
| Mar 31, 2015 | 57,000.00 |
| Dec 31, 2014 | 65,000.00 |
| Dec 31, 2014 | 65,000.00 |
| Sep 30, 2014 | 76,243.00 |
| Sep 30, 2014 | 76,243.00 |
| Jun 30, 2014 | 33,375.00 |
| Jun 30, 2014 | 33,375.00 |
| Mar 31, 2014 | 66,526.00 |
| Mar 31, 2014 | 66,526.00 |
| Dec 31, 2013 | 27,946.00 |
| Dec 31, 2013 | 27,946.00 |